Trial Profile
A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 14 Apr 2011 Status changed from active, no longer recruiting to completed, according to the ClinicalTrials.gov record.
- 12 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Nov 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.